Novartis | NVS - Market Capitalization


Novartis reported $282.49B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bausch Health Companies USD 2.61B 200M Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pacira USD 998M 83M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Zoetis USD 30.13B 19.58B Jun/2026